aTyr Pharma, Inc.ATYRNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank31
3Y CAGR+2.5%
5Y CAGR-8.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+2.5%/yr
vs -18.8%/yr prior
5Y CAGR
-8.7%/yr
Recent acceleration
Acceleration
+21.3pp
Accelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.74M | -2.8% |
| 2024 | $11.05M | -51.0% |
| 2023 | $22.54M | +125.9% |
| 2022 | $9.98M | +327.3% |
| 2021 | $2.34M | -86.2% |
| 2020 | $16.95M | +84.1% |
| 2019 | $9.21M | -59.9% |
| 2018 | $22.96M | +8.9% |
| 2017 | $21.09M | -45.1% |
| 2016 | $38.39M | - |